The Uromigos
The Uromigos
Broadcasting the latest developments in GU cancerHosted by Brian Rini and Tom Powles Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer CenterTom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
Mindenképp látogasd meg a podcast oldalát, és támogasd a készítőjét: www.uromigos.org
Szerző
The Uromigos
Kategória
A podcast weboldala
Legutóbbi epizód
2026. okt. 5.
Hol hallgathatod?
Podcastok az alkalmazásban Replaio Radio HamarosanA podcastok hamarosan megérkeznek az alkalmazásba. Telepítsd most, és láss elsőként egy teljesen új megközelítést a podcastokhoz
Telepítsd ingyen
Android közel 10 M letöltés · 4,8-as értékelés
iOS hamarosan
Epizódok
Episode 111: The randomised phase 3 CANTATA in metastatic renal cancer 08.06.2021 29:03
Nizar Tannir describes the results of this trial with a novel glutaminase inhibitor.
Episode 110: PEACE1 - Triplet therapy in prostate cancer 08.06.2021 27:51
Karim Fizazi describes the results of this randomised, potentially practice-changing trial.
Episode 109: Adjuvant pembrolizumab in renal cancer 07.06.2021 30:45
Toni Choueiri describes the KN564 study in detail.
Episode 108: Peter O'Donnell gives five year follow-up data on front line pembrolizumab in urothelial cancer 07.06.2021 24:09
Tom and Peter continue to see things differently - has the data changed things?
Episode 107: ASCO 2021: Neoadjuvant chemo/nivolumab as bladder sparing 07.06.2021 16:48
Matt Galsky describes his Phase 2 study and gives a vision of the future.
Episode 106: Summary of the three bladder sparing neoadjuvant trials at ASCO 2021 07.06.2021 26:01
Andrea Necchi gives a summary of the three abstracts.
Episode 105: A Phase 2 study of novel immune combinations (ICOS) in bladder cancer 07.06.2021 19:38
Arjun Balar discusses this and his neoadjuvant chemo/immune/RT trial.
Episode 104: Plenary Session 177lu-PSMA-617 in Prostate Cancer 06.06.2021 30:29
Mike Morris does his stuff.
Episode 103: Targeting the microbiome to increase the activity of immune therapy in renal cancer 06.06.2021 13:31
Monty Pal describes a small randomised trial of ipi/nivo plus CMB588.
Episode 102: Adjuvant therapy in melanoma - how it will help inform the renal community 28.05.2021 29:05
James Larkin describes learning from adjuvant immune checkpoint inhibitors in melanoma.
Episode 101: The Uromigos Paper of the Month - Belzutifan in renal cancer 26.05.2021 26:59
Eric Jonasch gives an overview of the recent Nature Medicine publication.
Episode 100: The Uromigos 100th Podcast - Looking to the Future 21.05.2021 36:24
Chris Sweeney, Kala Sridhar and David McDermott discuss the future.
Episode 99: Navigating social media from a patients' perspective 19.05.2021 24:58
Dena Battle is the co-founder and president of KCure and a passionate kidney cancer patient advocate.
Episode 98: Bladder cancer from a patient perspective 19.05.2021 23:35
Dr. Lydia Makaroff, Vice President of the World Bladder Cancer Patient Coalition, discusses key issues for bladder cancer.
Episode 97: Sacituzumab Govitecan in Bladder Cancer 04.05.2021 18:21
Petros Grivas discusses the recent accelerated approval and JCO paper data.
Episode 96: ODAC Bladder Cancer Accelerated Approval Meetings with Andrea Apolo 28.04.2021 26:23
Andrea Apolo discusses highlights from the April 28th meeting.
Episode 95: ODAC Overview and Bladder Accelerated Approval Meetings with Jorge Garcia 28.04.2021 26:55
Jorge Garcia discusses the pembrolizumab and atezolizumab bladder cancer dangling accelerated approvals and the ODAC process
Episode 94: EIKCS Summary of Day 1 23.04.2021 24:40
Samra Turajlic summarised the meetings and looks forward to Day 2...
Episode 93: The Uromigos Paper of the Month - A new risk classification for germ cell cancer 14.04.2021 23:49
Silke Gillessen discusses the back to back JCO papers on this topic.
Episode 92: Second line therapy in advanced RCC 09.04.2021 27:31
Viktor Grünwald discusses treatment for progression of disease after front lines PD1 based therapy.
Episode 91: The Uromigos Paper of the Month - Adjuvant atezolizumab in bladder cancer 26.03.2021 29:05
Joaquim Bellmunt describes this study as well as adjuvant nivolumab and ctDNA in bladder cancer.
Episode 90: The Uromigos Podcast with QOL Expert David Cella 12.03.2021 27:46
Everything you wanted to know about quality of life assessment in cancer but were too afraid to ask.
Episode 89: The Uromigos Paper of the Month - Pembrolizumab in clear cell and non-clear cell renal cancer 04.03.2021 28:14
David McDermott describes these back to back JCO publications.
Episode 88: Career Development in Academic Oncology Part 3 - Walter Stadler 26.02.2021 23:14
In these podcasts, we explore academic career development with individuals in different stages of their career.
Episode 87: Career Development in Academic Oncology Part 2 - Monty Pal 26.02.2021 22:17
In these podcasts, we explore academic career development with individuals at different stages in their career.
Hasonló podcastok
Hallgasd a(z) The Uromigos podcastot a Replaióban
Rádió és podcastok egy alkalmazásban - ingyen és regisztráció nélkül. Telepítsd még ma, és ne maradj le a premierről
A Replaio nem podcastkiadó; a műsorok nevei, borítóképei és hanganyagai a szerzőiket illetik, és nyilvános RSS-csatornákon keresztül terjednek.
